ICAAC 51st

Title Content type
M-1507 - Incubation Period of Invasive Aspergillosis in Immunocompromised Patients Undergoing Aplasia Based on Parametric Survival Models (click for details)
M-1540 - Comparative Evaluation of the Vitek-2 Yeast Susceptibility Test against the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Methods for Testing Candida (click for details)
M-290 - Galactomannan Index: Variations According to the Aspergillus Species Involved (click for details)
M-293 - The Population Structure of Aspergillus fumigatus Clinical Isolates: Role of Azole Drugs in Selecting Less-Susceptible Clonal Complexes (click for details)
M-280 - Prophylactic Effectiveness & Safety of Intermittent Liposomal Amphotericin in High Risk Haematological Patients (click for details)
M-1136 - Randomized Controlled Trial of Two Diagnostic Strategies for Invasive Aspergillosis (IA) in High-Risk Hematology Patients (click for details)
A2-580 - Dose Ranging Pharmacodynamics (pd) of Echinocandin (e) and Triazole (t) Combination Antifungal therapy in An in vivo Pulmonary Aspergillosis (ipa) Model (click for details)
M-490 - Prospective International Surveillance of Azole Resistance (AR) in Aspergillus fumigatus (Af) (SCARE-Network) (click for details)
F1-1379 - Identification and Characterization of Novel Small Molecule Inhibitors Against Resistant Fungal Pathogens (click for details)
M-1520 - Invasive Aspergillosis (IA) in Patients with Chronic Obstructive Pulmonary Disease (COPD): Results from a Prospective, Multicentric Study (click for details)


Subscribe to ICAAC 51st